GeneDx Holdings (WGS) Return on Invested Capital (2022 - 2023)
GeneDx Holdings (WGS) posted quarterly Return on Invested Capital of 0.29% for Q4 2023, up 29.0% year-over-year from 0.23% in Q4 2022, and up 45.9% quarter-over-quarter from 0.54% in Q3 2023.
GeneDx Holdings (WGS) Return on Invested Capital (2022 - 2023) Analysis & Trends
GeneDx Holdings (WGS) has reported Return on Invested Capital for 2 consecutive years, with 0.29% the latest figure, recorded in Q4 2023.
- In Q4 2023, Return on Invested Capital rose 29.0% year-over-year to 0.29%; the TTM figure through Dec 2023 stood at 0.29% (up 29.0% YoY), while the FY2022 annual figure was 1.97%, changed N/A from the prior year.
- Return on Invested Capital improved to 0.29% in Q4 2023 per WGS's latest filing, from 0.54% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.29% in Q4 2023 and bottomed at 0.58% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 0.01% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 0.02% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 0.01% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.02% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 0.00% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -0.01% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 0.04% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 0.01% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | -0.54% |
| Jun 30, 2023 | -0.48% |
| Mar 31, 2023 | -0.51% |
| Dec 31, 2022 | -0.58% |
| Sep 30, 2022 | -0.40% |
| Jun 30, 2022 | -0.39% |